Ventyx Biosciences Inc (NASDAQ: VTYX) kicked off on Monday, down -5.91% from the previous trading day, before settling in for the closing price of $2.54. Over the past 52 weeks, VTYX has traded in a range of $1.79-$17.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 34.66%. With a float of $54.69 million, this company’s outstanding shares have now reached $59.24 million.
The firm has a total of 80 workers. Let’s measure their productivity. In terms of profitability, gross margin is -29.37%, operating margin of -17061.06%, and the pretax margin is -15920.26%.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 22.62%, while institutional ownership is 71.84%. The most recent insider transaction that took place on Apr 02 ’24, was worth 8,921. In this transaction CHIEF BUSINESS OFFICER of this company sold 1,651 shares at a rate of $5.40, taking the stock ownership to the 284,999 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 264,998 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 34.66% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Take a look at Ventyx Biosciences Inc’s (VTYX) current performance indicators. Last quarter, stock had a quick ratio of 14.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.79, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Analysing the last 5-days average volume posted by the [Ventyx Biosciences Inc, VTYX], we can find that recorded value of 0.58 million was lower than the volume posted last year of 2.13 million. As of the previous 9 days, the stock’s Stochastic %D was 75.44%. Additionally, its Average True Range was 0.15.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 15.50%, which indicates a significant decrease from 63.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.45% in the past 14 days, which was lower than the 110.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.20, while its 200-day Moving Average is $3.57. Now, the first resistance to watch is $2.51. This is followed by the second major resistance level at $2.62. The third major resistance level sits at $2.71. If the price goes on to break the first support level at $2.31, it is likely to go to the next support level at $2.22. Now, if the price goes above the second support level, the third support stands at $2.11.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
The company with the Market Capitalisation of 168.90 million has total of 70,499K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -192,960 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -31,950 K.
